Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

myelodysplastic syndrome with multilineage dysplasia - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

myelodysplastic syndrome with multilineage dysplasia

MONDO:0019453

Also known as:MDS-MLDRCMDrefractory cytopenia with multilineage dysplasia

Overview

Refractory cytopenias with multilineage dysplasia (RCMD) is a frequent subtype of myelodysplastic syndrome (MDS) characterized by 1 or more cytopenias in the peripheral blood and dysplasia in 2 or more myeloid lineages.

ResearchLimited published research (5 articles)

Diagnosis

Biomarker and diagnostic research for myelodysplastic syndrome with multilineage dysplasia has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for myelodysplastic syndrome with multilineage dysplasia.

5 publications have been identified in PubMed for myelodysplastic syndrome with multilineage dysplasia. Research spans Epidemiology / Natural History (40%), Diagnostic / Biomarker (20%), and Review / Meta-Analysis (20%).

Recent Publications

Cebeci S (2026). [PMID: 41904024](https://pubmed.ncbi.nlm.nih.gov/41904024/). *Clin Lymphoma Myeloma Leuk*. [Epidemiology / Natural History]
Waheed A (2025). [PMID: 40269371](https://pubmed.ncbi.nlm.nih.gov/40269371/). *J Pak Med Assoc*. [Diagnostic / Biomarker]
Ma Q (2024). [PMID: 39192417](https://pubmed.ncbi.nlm.nih.gov/39192417/). *Zhongguo Shi Yan Xue Ye Xue Za Zhi*. [Basic Science / Preclinical]
Jonasova A (2024). [PMID: 39416466](https://pubmed.ncbi.nlm.nih.gov/39416466/). *Front Oncol*. [Epidemiology / Natural History]
Komrokji RS (2024). [PMID: 39393368](https://pubmed.ncbi.nlm.nih.gov/39393368/). *Lancet Haematol*. [Review / Meta-Analysis]

Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:39 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:86836

GARD

Genetic and Rare Diseases Info Center

GARD:19069

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

myelodysplastic syndrome with multilineage dysplasia

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team